• BQCA and the Next Logic of M1 Signaling

  2026-09-04

  Benzyl Quinolone Carboxylic Acid (BQCA) offers a strategic way to study M1 muscarinic receptor signaling as a tunable, pathway-dependent process rather than a simple on/off response. This thought-leadership analysis connects BQCA’s pharmacology with GRK-regulated signaling bias, translational study design, and decision-making in cognitive and Alzheimer’s disease research.

• HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody

  2026-09-04

  Build clearer fluorescence workflows for neuroblastoma nanocarrier studies with a spectrally defined goat anti-rabbit IgG secondary antibody. This guide connects immunocytochemistry, tissue imaging, flow cytometry, and ELISA readouts to the iRGD-modified red blood cell membrane photodynamic therapy model.

• Topotecan HCl and DNA Damage Burden

  2026-09-03

  Topotecan HCl is a topoisomerase 1 inhibitor that converts replication-associated lesions into actionable DNA damage signals. This article presents a cell-state and repair-capacity framework for interpreting its activity across cancer assays while carefully connecting those principles to new findings on selective CUX2 neuron loss in neuroinflammation.

• Gamma-linolenic Acid: Applied Research Workflows

  2026-09-03

  Build reproducible GLA experiments around lipid handling, LTB4-linked inflammatory assays, viability profiling, and disease-relevant cell models. The workflow also clarifies what can—and cannot—be inferred from new arachidonic acid vaccine-adjuvant findings.

• HRP Goat Anti-Mouse IgG (H+L) Antibody Guide

  2026-09-02

  HRP Goat Anti-Mouse IgG (H+L) Antibody, SKU K1221, provides an HRP-based detection layer for mouse IgG primary antibodies in Western blotting, ELISA, IHC, and ICC. It should not be treated as a universal secondary antibody for other host species, non-IgG mouse immunoglobulins, or fluorescence workflows without separate validation.

• EdU Imaging Kits (Cy3) for Locust Gut Studies

  2026-09-02

  EdU Imaging Kits (Cy3) convert DNA-replication activity into a bright Cy3 signal for microscopy or flow cytometry, enabling direct measurement of proliferating gut cells. The workflow complements RNAi and hormone-rescue experiments in Locusta migratoria by separating effects on S-phase entry from downstream tissue and molting phenotypes.

• Etomoxir A3404 for Reliable Metabolic Assays

  2026-09-01

  Learn how Etomoxir (SKU A3404) can improve interpretation of viability, proliferation, cytotoxicity, and immunometabolic assays by providing a defined CPT-1 perturbation. This scenario-based guide covers concentration selection, solvent handling, whole-blood compatibility, data interpretation, and practical product-selection criteria.

• Irinotecan Workflows for Colorectal Cancer Research

  2026-09-01

  Build more interpretable irinotecan experiments by separating prodrug activation, topoisomerase I–linked DNA damage, and downstream cell death. This workflow guide covers cell-based screening, xenograft translation, assay timing, solubility control, and troubleshooting for reproducible colorectal cancer research.

• Tiamulin (Thiamutilin): Mechanism & Use

  2026-08-31

  Tiamulin, also called Thiamutilin, is a semi-synthetic pleuromutilin antibiotic used mainly in pigs and poultry. It inhibits bacterial protein synthesis at the 50S ribosomal subunit and has separately reported anti-inflammatory activity, but dosing, residue control, and species-specific evidence remain essential.

• Prunin Targets Senecavirus A IRES-Dependent Replication

  2026-08-31

  The reference study reports that prunin suppresses Senecavirus A replication in cell culture and an animal model, with evidence implicating the viral internal ribosome entry site as a mechanistic target. Its main contribution is to connect an antiviral phenotype with a defined translation-control element, while also highlighting the need for orthogonal replication, toxicity, and in vivo validation.

• Macrophage Depletion as a Test of Liver Repair

  2026-08-30

  A translational framework for using Clodronate Liposomes to test whether macrophage states are causal drivers of hepatic ischemia-reperfusion injury, rather than merely correlates identified by single-cell analysis.

• Biomarkers Sharpen In Vitro Micronucleus Assays

  2026-08-29

  Avlasevich and colleagues combined flow-cytometric micronucleus scoring with DNA damage-response biomarkers to distinguish bona fide genotoxicity from irrelevant positive results associated with cytotoxicity. In a reference-chemical panel, requiring concordant micronucleus and biomarker responses markedly improved specificity while preserving sensitivity, creating a more informative framework for mode-of-action and potency assessment.

• (Z)-4-Hydroxytamoxifen in Relapse Assays

  2026-08-28

  Explore how (Z)-4-Hydroxytamoxifen can sharpen estrogen receptor experiments while clarifying the biological limits of proliferation-ablation relapse models. This article connects ER pharmacology, assay design, and recurrence biology without treating distinct mechanisms as interchangeable.

• LDN-193189: BMP Signaling and Cell Plasticity

  2026-08-28

  LDN-193189 is an ALK inhibitor that enables receptor-level dissection of BMP signaling alongside TGF-β-driven epithelial plasticity. This guide translates mechanistic findings on Sca-1 regulation into practical assay designs, controls, and interpretation strategies.

• HyperScribe T7 High Yield RNA Synthesis Kit Workflow

  2026-08-27

  Build a reliable T7 transcription workflow for long, labeled, capped, or modified RNA, with practical controls for yield and quality. The guide also translates a recent LINC02613–LCP1 metastasis study into actionable RNA probe, pull-down, and interference-assay choices.

8459 records 1/564 page Next 12345 下5页 Last page